Works by Mengjie Ding


Results: 15
    1
    2
    3
    4

    Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.

    Published in:
    Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1089, doi. 10.20892/j.issn.2095-3941.2021.0026
    By:
    • Jingjing Wu;
    • Fenghua Gao;
    • Wenhua Wang;
    • Xudong Zhang;
    • Meng Dong;
    • Lei Zhang;
    • Xin Li;
    • Ling Li;
    • Zhenchang Sun;
    • Xinhua Wang;
    • Xiaorui Fu;
    • Linan Zhu;
    • Mengjie Ding;
    • Songtao Niu;
    • Zhaoming Li;
    • Yu Chang;
    • Feifei Nan;
    • Jiaqian Yan;
    • Hui Yu;
    • Xiaolong Wu
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.687374
    By:
    • Hu, Junxia;
    • Wang, Xin;
    • Chen, Fei;
    • Ding, Mengjie;
    • Dong, Meng;
    • Yang, Wanqiu;
    • Yin, Meifeng;
    • Wu, Jingjing;
    • Zhang, Lei;
    • Fu, Xiaorui;
    • Sun, Zhenchang;
    • Li, Ling;
    • Wang, Xinhua;
    • Li, Xin;
    • Guo, Shuangshuang;
    • Zhang, Dianbao;
    • Lu, Xiaohui;
    • Leng, Qing;
    • Zhang, Mingzhi;
    • Zhu, Linan
    Publication type:
    Article
    14
    15